BSE filing, NSE: ARMANFIN. Summary written from the filing by ALFA Finder's alert engine.
Arman Financial Services Ltd: key numbers
- Share price
- ₹1,420.00
- Market cap
- ₹1,498 Cr
- Revenue (annual)
- ₹645.9 Cr
- Net profit (annual)
- ₹56.61 Cr
- P/E (TTM)
- 12.9×Sector 19.7×
- Promoter holding
- 21.93%-0.07% QoQ
- FII holding
- 2.85%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arman Financial Services Ltd
All →Arman Financial Services Credit Rating
CARE Ratings reaffirmed Arman Financial's 'CARE A-' rating on its NCDs and revised the outlook from Negative to Stable, covering its subsidiary Namra Finance too. The rated facilities total ₹42.00 crore plus a proposed ₹28.89 crore NCD issue.
Arman Financial Services Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ending September 30, 2026.
Arman Financial Services Management Change
Arman Financial Services Limited appointed Mr. Chandramouli Akkiraju as Chief Business Officer of its wholly owned subsidiary, Namra Finance Limited, effective October 16, 2026.
Arman Financial Services Promoter Selling
Promoter Himani Manakiwala sold 500 Arman Financial Services shares in the open market. The reduction trimmed his stake from 4,834 to 4,334 shares.
- Promoter stake change
- -0.01%
Arman Financial Services Debt & Borrowing: ₹0.22 Cr
Arman Financial Services Limited paid Rs. 0.22 Crore in monthly interest for its NCDs. The payment was completed on October 05, 2026, for ISIN INE109C07105.
- Value
- ₹0.22 Cr
Arman Financial Services Credit Rating
Acuité Ratings has reaffirmed the long-term rating of 'ACUITE A-' for Arman Financial Services. The outlook has been revised upward from 'Stable' to 'Positive' for its credit facilities.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.